Skip 
Navigation Link

1215 South Walnut Ave.
Demopolis, AL 36732 map map 

Access to Care: 1-800-239-2901

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
'Green Prescriptions' May Backfire for SomePreventive Health Care Falls by Wayside During PandemicSmoking Bans Don't Work If Not Enforced, NYC Study FindsTelemedicine Out of Reach for Those Who Can't Get OnlineLies Spread on Social Media May Mean Fewer Vaccinations1 in 3 Americans Prescribed Inappropriate DrugsColon Cancer Screening Should Start at Age 45: Task ForceWhat Will It Take for People to Embrace a COVID Vaccine?What Will Convince Americans to Get a COVID-19 Vaccine?CDC Recommends Face Masks in All Public Transportation SettingsInsured Patients Are Getting Surprise Bills After ColonoscopiesBogus 'Cure' Claims Have U.S. Consumers Snapping Up CBD ProductsPediatricians' Group Tackles Racism in Health CareAs Virtual Doctor Visits Spike, Concerns About Equity, Missed Diagnoses GrowWas FDA Lax in Approving Opioids Too Easily?Allowing More Gay Men to Donate Corneas Could Save Sight for Thousands: StudyAccuracy of COVID-19 Antibody Tests Varies Widely, Study FindsCould Drones Delivering Defibrillators Save Lives?Statins Going Generic Saved Medicare BillionsAHA News: Looming Wave of Evictions, Housing Instability Pose Threat to HealthAHA News: Health Apps Pose Privacy Risks, But Experts Offer This AdviceCould You Save a Life After Mass Violence? Most Americans Say NoGun Violence Costs U.S. Health Care System $170 Billion AnnuallyWith COVID Vaccine in Works, 1 in 5 Americans Doesn't Believe in ShotsTelehealth Skyrocketing Among Older AdultsPharmacists in All U.S. States Can Give Kids Childhood ShotsAHA News: COVID-19's Economic Fallout Expands Food Insecurity, as Groups Scramble to HelpCOVID-19 Clinical Trials Lack Diversity, Researchers SayLook Beyond Fossil Fuels to Curb Air PollutionTelemedicine Is Here: Experts Offer Tips for SeniorsMany Older Adults Can't Connect With Telehealth: StudyAHA News: High-Speed Internet Offers Key Connection to Health, But Millions Lack It11 States Could Face ICU Doc Shortages as Coronavirus Cases SurgeWill the Telemedicine Boom Outlast the Pandemic?Yet Another Study Finds Vaccines Are SafeIn Rush to Publish, Most COVID-19 Research Isn't Reliable, Experts SayWith Tighter Handgun Laws, U.S. Would See Fewer Suicides by Young PeoplePandemic Has ER Docs Stressed Out and Weary: SurveyU.S. Air Quality Got Better During Pandemic: StudyColon Cancer Tests by Mail Might Boost ScreeningWill CPR Save Your Life? Study Offers a Surprising AnswerWill COVID Pandemic's Environmental Benefit Last?AHA News: As Pandemic Disrupts Research, Scientists Look for New Ways ForwardAmericans Lag Behind Brits When It Comes to HealthBan Menthol Cigarettes, Lower Smoking Rates?Tech Is Keeping More Americans in Touch With DoctorsEven Small Reductions in Air Pollution Help The HeartHigh Costs Lead Millions of Americans to Shop Abroad for Rx DrugsPandemic Hits Primary Care Practices Hard Across the U.S.: StudyOne-Time Treatment Eases Parkinson's -- in Mice
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

Bogus Coronavirus 'Meds' Targeted by FDA

HealthDay News
by -- Robert Preidt
Updated: Mar 9th 2020

new article illustration

MONDAY, March 9, 2020 (HealthDay News) -- U.S. officials are cracking down on companies selling fraudulent products that claim to prevent or treat the new coronavirus.

Seven companies -- whose goods range from essential oils to colloidal silver -- were sent warning letters from the U.S. Food and Drug Administration and the U.S. Federal Trade Commission, the FDA said Monday.

"The FDA considers the sale and promotion of fraudulent COVID-19 products to be a threat to the public health," FDA Commissioner Dr. Stephen Hahn said in an agency news release.

"We have an aggressive surveillance program that routinely monitors online sources for health fraud products, especially during a significant public health issue such as this one," he added.

Currently, there are no vaccines or drugs approved to treat or prevent COVID-19, the FDA said.

The warning letters were sent to: Vital Silver; Quinessence Aromatherapy Ltd.; Xephyr LLC doing business as N-Ergetics; GuruNanda, LLC; Vivify Holistic Clinic; Herbal Amy LLC, and The Jim Bakker Show.

Besides essential oils and colloidal silver, the products in question include teas and tinctures. These unapproved drugs pose significant health risks and violate federal law, the FDA noted.

Colloidal silver isn't safe or effective for treating any condition, the FDA has said in the past.

Products that falsely claim to cure, treat or prevent serious diseases like COVID-19 may lead people to delay or stop appropriate medical treatment, resulting in serious and life-threatening harm, the FDA warned.

"We understand consumers are concerned about the spread of COVID-19 and urge them to talk to their health care providers, as well as follow advice from other federal agencies about how to prevent the spread of this illness. We will continue to aggressively pursue those that place the public health at risk and hold bad actors accountable," Hahn said.

Since the outbreak of COVID-19 reached the United States, some consumers have also faced much higher-than-normal prices for products such as face masks, hand sanitizers and disinfectant wipes.

Online sales of virus protection products have spiked 817% in the last two months, and prices have skyrocketed, CBS News reported.

There is a high level of anxiety over the potential spread of coronavirus, said Joe Simons, FTC chair.

"What we don't need in this situation are companies preying on consumers by promoting products with fraudulent prevention and treatment claims. These warning letters are just the first step. We're prepared to take enforcement actions against companies that continue to market this type of scam," Simons added.

The companies that received the warning letters have 48 hours to outline steps taken to correct the violations. Companies selling products that falsely claim to prevent, treat or cure COVID-19 may face legal action, including seizure or injunction.

The FDA and FTC also said they'll continue to monitor social media, online marketplaces and complaints to help ensure that the companies do not continue to sell bogus products under a different company name or on another website.

The FDA has created a cross-agency task force to closely monitor for fraudulent products related to COVID-19.

More information

The U.S. Centers for Disease Control and Prevention has more on COVID-19.